Mutual Fund Details
NAV
₹37.9471
as on 22 Sep 2026, 11:27 PM
₹-0.2005(0.53%)
Last Change
Scheme Ratings
1
rated byValue Research
Pharma
Rankings based on | as on Invalid date
×
Download the Paytm Money app now!
Invest in Stocks, F&O, Mutual Funds, IPOs, NFOS and Bonds.
Zero brokerage for 30 days- Zero account opening fees
- Zero AMC for life
Scan QR code to download the app
Investment Performance
would have given a return of
₹1,10,871
₹1,21,647
₹1,81,056
₹1,87,993
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹87,993
Profit (absolute return)
87.99%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 1 month
2.70%
In the last 3 months
12.02%
In the last 6 months
21.94%
In the last 1 year
17.15%
In the last 3 years
87.99%
In the last 5 years
80.54%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low to moderate
moderate
moderately high
high
very high
Investors understand that their principal will be at very high risk
Scheme Information
LIC MF Healthcare Fund Direct-IDCW Reinvestment
as of 31 Aug 2026, 05:30 AM
₹103.11 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
1.37%
Expense Ratio
Plan
Dividend
Benchmark
BSE Healthcare Total Return Index
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Scheme Document
Sectors Holding in this Mutual Fund
as on31 Aug 2026
Healthcare
92.87%
₹95.75 Cr
Chemicals
5.65%
₹5.83 Cr
Cash Holding
1.48%
₹1.53 Cr
Companies Holding in this Mutual Fund
as on31 Aug 2026
Sun Pharmaceutical Industries Ltd.
10.09%
₹10.40 Cr
Divi's Laboratories Ltd.
9.29%
₹9.58 Cr
Torrent Pharmaceuticals Ltd.
6.45%
₹6.65 Cr
Neuland Laboratories Ltd.
6.38%
₹6.58 Cr
Apollo Hospitals Enterprise Ltd.
6.23%
₹6.42 Cr
Others
61.56%
₹63.47 Cr
View All
View All
Companies Holding in this Mutual Fund
as on31 Aug 2026
Sun Pharmaceutical Industries Ltd.
10.09%
₹10.40 Cr
Divi's Laboratories Ltd.
9.29%
₹9.58 Cr
Torrent Pharmaceuticals Ltd.
6.45%
₹6.65 Cr
Neuland Laboratories Ltd.
6.38%
₹6.58 Cr
Apollo Hospitals Enterprise Ltd.
6.23%
₹6.42 Cr
Others
61.56%
₹63.47 Cr
View All
View All
This fund's returns:
23.40%Return Duration
3 Years
UTI Healthcare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
19.36%
25.10%
3Y Returns
25.10
SBI Healthcare Opportunities Fund Direct Plan-Growth
EquityPharma
Min. Investment
₹500
Category Returns
19.36%
25.10%
3Y Returns
24.69
Mirae Asset Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
19.36%
25.10%
3Y Returns
23.42
AboutLIC MF Healthcare Fund Direct-IDCW Reinvestment
LIC MF Healthcare Fund Direct-IDCW Reinvestment is aEquity mutual fund scheme fromLIC Mutual Fund. This scheme was launched onInvalid date. It has an AUM of ₹103.11 Crores and the latest NAV decalared is ₹37.947 as on23 Sep 2026 at4:51 am.
LIC MF Healthcare Fund Direct-IDCW Reinvestment scheme return performance in last 1 year is 17.15%, in last 3 years is 87.99% and 276.99% since scheme launch. The min. SIP amount to invest in this scheme is ₹200.
Scheme Details
| AUM: | ₹103.11 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | Invalid date |
| Fund Type: | Open-End |
AMC Information
LIC Mutual Fund
View AMC Details
₹45,910.63 Cr
AUM
128
Schemes
Address
Industrial Assurance BuildingGround Floor, Opp. Churchgate Station400020
Phone Number
Phone :022-66016177 / 022-66016178
Fax :022-22880633
Email / Website
Start investing in minutes
Download app to Explore
Scan this QR code to download the app now!
Or download from
